Abstract:Abstract Background: Mycoplasma hyopneumoniae ( M.hyo ) is one of the most prevalent pathogens causing respiratory disorders in swine populations as well as primary agent of porcine respiratory disease complex (PRDC). The aim of this trial is to compare the efficacy of two commercial vaccines under field conditions, applied via different routes of administration, as a tool to control disease. Results: 3 groups each consisting of 440 animals, were included in this longitudinal study; one group vaccinated against M.hyo with an intradermal vaccine (group I), a second group vaccinated with an intramuscular vaccine 2940 strain (group H) and finally a third group, not vaccinated as a control (group N). All animals were individually weighed at weaning; upon entry into the fattening unit and just prior to movement to the slaughterhouse. Pigs from each group were periodically blood sampled to evaluate the immunological status against other pathogens involved in PRDC. Tracheobronchial swabs were collected from 30 pigs per treatment group during the final weighing. Slaughterhouse lung lesion evaluations were developed to assess levels of enzootic pneumonia-like lesions (EP) and pleuritis (P).Statistical evaluation of all test parameters indicated a better performance of the intradermal vaccinated group (group I):· in terms of weight (kg) just prior to movement to the slaughterhouse, (I= 97.45; H = 93.44; N = 93.05).· The number of positive tracheobronchial swabs, as well as M.hyo load detected individually (I = 36.7% positive samples with log10 Ct average value 1.48; H = 100% with log10 Ct 1.40; and N = 96.7% with log10 Ct 1.40),· EP prevalence (I = 35.1%, H = 47.0%, N = 50.5%) and· Pleurisy prevalence (I = 22.4%, H = 29.7%, N = 39.3%).In terms of the involvement of other PRDC pathogens, the serological study could lead us to think that the agents studied were present at same level in the all 3 vaccination groups. Conclusion: In this study, intradermal vaccination provided better performance than unvaccinated control group and intramuscular vaccine, in terms of weight increase (versus intramuscular group); reduction of enzootic pneumonia and pleurisy lesions, and tracheobronchial M.hyo prevalence at the end of the finishing period.

Dynamics of Mycoplasma hyopneumoniae seroconversion and infection in pigs in the three main production systems

Mycoplasma hyopneumoniae infection dynamics in naïve replacement gilts introduced to positive farms

Genomic Variability and Post-translational Protein Processing Enhance the Immune Evasion of Mycoplasma Hyopneumoniae and Its Interaction with the Porcine Immune System

Long-term follow-up of Mycoplasma hyopneumoniae-specific immunity in vaccinated pigs

Influence of Mycoplasma hyopneumoniae natural infection on the respiratory microbiome diversity of finishing pigs

Seroprevalence of Mycoplasma hyopneumoniae in sows fifteen years after implementation of a control programme for enzootic pneumonia in Switzerland

Characterization of Mycoplasma hyopneumoniae strains in vaccinated and non-vaccinated pigs from Spanish slaughterhouses

Effect of vaccination against Mycoplasma hyopneumoniae on divergent pig genetic groups

Environmental detection of Mycoplasma hyopneumoniae in breed-to-wean farms

Development of ELISA Using Recombinant Proteins for the Diagnosis of Mycoplasma hyopneumoniae Infection

Dynamics of antibody response and bacterial shedding of Mycoplasma hyorhinis and M. hyosynoviae in oral fluids from experimentally inoculated pigs

Rationalizing the use of common parameters and technological tools to follow up Mycoplasma hyopneumoniae infections in pigs

Exploring the Genetic Diversity of Mycoplasma hyopneumoniae in Pigs with Pneumonia and Pleurisy at Slaughter

Transfer of Mycoplasma hyopneumoniae-specific cell mediated immunity to neonatal piglets

Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines

Field Trial Assessment of Two Commercial Vaccines Against Mycoplasma Hyopneumoniae

Immune B cell responsiveness to single-dose intradermal vaccination against Mycoplasma hyopneumoniae

Mycoplasmal pneumonia of swine: Update and importance of the disease

Effect of sow mass vaccination against Mycoplasma hyopneumoniae on the humoral immune response of newborn piglets

Differential Gene Expression in Porcine Lung Compartments after Experimental Infection with Mycoplasma hyopneumoniae

Discovery of the rich diversity of Mesomycoplasma hyopneumoniae through high-throughput sequencing